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Two HIV-1 accessory proteins, Vpu and Vif, are notoriously difficult to express autonomously in the absence of the viral Tat and Rev
proteins. We examined whether the codon bias observed in the vpu and vif genes relative to highly expressed human genes contributes to the
Rev dependence and low expression level outside the context of the viral genome. The entire vpu gene as well as the 5V half of the vif gene
were codon optimized and the resulting open reading frames (ORFs) (vphu and hvif, respectively) were cloned in autonomous expression
vectors under the transcriptional control of the CMV promoter. Codon optimization efficiently removed the expression block observed in the
native genes and allowed high levels of Rev- and Tat-independent expression of Vpu and Vif. Most of the higher protein levels detected are
accounted for by enhanced steady-state levels of the mRNA encoding the optimized species. Nuclear run-on experiments show for the first
time that codon optimization has no effect on the rate of transcriptional initiation or elongation of the vphu mRNA. Instead, optimization of
the vpu gene was found to stabilize the vphu mRNA in the nucleus and enhance its export to the cytoplasm. This was achieved by allowing
the optimized mRNA to use a new CRM1-independent nuclear export pathway. This work provides a better understanding of the molecular
mechanisms underlying the process of codon optimization and introduces novel tools to study the biological functions of the Vpu and Vif
proteins independently of other viral proteins.
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Introduction genomic RNA and individual HIV-1 mRNAs coding for theExpression of the HIV-1 genes is tightly controlled,
allowing exquisite temporal modulation of regulatory and
structural gene expression. Two regulatory proteins of HIV,
Tat and Rev, have a critical role in the transcriptional and
posttranscriptional regulation of viral gene expression. Tat
acts as a transcriptional activator of the HIV long terminal
repeat (LTR) by binding to the TAR element found at the 5V
end of all HIV-1 transcripts (Jeang et al., 1999). Transcription
of HIV genes is initiated from a single promoter located in the
5V LTR. The primary transcript corresponds to the full-length0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2003.11.021
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E-mail address: sbour@niaid.nih.gov (S. Bour).nine viral proteins or protein precursors are generated by
differential splicing of the primary transcript. Early gene
products such as Tat, Rev, and Nef are translated from doubly
spliced messages that are efficiently exported from the
nucleus. Unspliced and singly spliced messages encoding
Vif, Vpr, Vpu, and the viral Gag, Pol and Env contain an RNA
stem–loop structure termed the Rev-responsive element
(RRE) located in the env gene. Mechanistically, Rev has
been shown to facilitate HIV RNA export by binding to the
RRE and by simultaneously interacting with the CRM1/Ran
complex, which in turn interacts with components of the
nuclear pore complex to mediate the energy-dependent
translocation of the RNAmolecule into the cytoplasm (Kjems
and Askjaer, 2000).
While recent data have clarified the role of Rev in
facilitating RRE-containing RNA nuclear export, much
remains to be learned to fully understand the reason for the
K.-L. Nguyen et al. / Virology 319 (2004) 163–175164Rev dependence of HIV messages. Indeed, numerous studies
have indicated that the RRE is not the main element
responsible for nuclear retention of viral mRNA in the
absence of Rev (Chang and Sharp, 1989). Instead, regions
of high AU content (Maldarelli et al., 1991; Schwartz et al.,
1992a) as well as AUUUA motifs (Schneider et al., 1997),
collectively referred to as cis-acting inhibitory elements
(INS), have been identified and largely account for the
nuclear retention of unspliced and singly spliced HIV-1
mRNAs. Selective inactivation of the INS in HIV-1 gag
and pol genes has resulted in enhanced levels of Rev-
independent expression and correlated with increased levels
of cytoplasmic mRNA (Schneider et al., 1997). Reduction of
the AU content and removal of AUUUA sequences can also
be achieved globally on mRNA sequences by a process
referred to as codon optimization. This strategy does not
require the prior identification and mapping of INS sequen-
ces and involves the optimization of the viral coding se-
quence to approximate the codon usage observed in highly
expressed human genes (Kypr and Mrazek, 1987). When
applied to HIV-1 genes, this strategy has allowed increased
Rev-independent expression of the Env, Gag, and Pol gene
products (Haas et al., 1996; Kotsopoulou et al., 2000). The
mechanism responsible for enhanced expression of codon-
optimized genes remains poorly defined. Indeed, while
codon replacement in the HIV-1 env gene led to increased
protein levels with no detectable effect on RNA stability
(Haas et al., 1996), increased mRNA levels in the cytoplasm
accounted for most of the enhanced expression of the codon-
optimized gag and pol genes (Kotsopoulou et al., 2000;
Schneider et al., 1997). Two main mechanisms have been
proposed to account for this enhanced cytoplasmic export of
codon-optimized RNA. A first factor is the stabilization of
the nuclear RNA due to a reduction in the global AU content
as well as the inactivation of AUUUA AU-rich elements
(AREs). The negative effect of AU-rich regions and various
ARE motifs on RNA stability is well documented (Hol-
lams et al., 2002). They often account for the inherent
instability of a given RNA and can confer instability to
otherwise stable RNA. Second, codon-optimized HIV-1
Gag mRNAs gain access to Rev- and CRM1-independent
nuclear export pathways, leading to more efficient trans-
port of unspliced RNA to the cytoplasm (Graf et al.,
2000). With the notable exception of HIV genes, most of
the AU-rich and ARE sequences have been located in the
3V untranslated region (UTR) of cellular messages.
We sought to clarify the molecular mechanisms respon-
sible for enhanced expression following codon optimization
and its relationship with the presence of INS or AUUUA
repeats. The Vpu protein is translated from a bicistronic
mRNA that also contains the env open reading frame (ORF)
(Schwartz et al., 1992b). Therefore, despite the fact that the
RRE is at a considerable distance from the vpu ORF,
expression of Vpu in its native context is rendered Rev-
responsive. The Vpu and Vif proteins express poorly from
autonomous expression vectors, suggesting that the Rev/RRE serve to relieve an inherent expression inhibitor present
in the ORF of these two accessory proteins.
The ability of HIV-1 Vif to promote viral infectivity as
well as the property of Vpu to enhance viral particle release
(Bour and Strebel, 2000) make these two factors important
for many applications such as gene therapy. Yet, low expres-
sion levels of Vpu and Vif have hampered not only the
molecular characterization of their biological functions, but
have also prevented their use in the production of recombi-
nant retroviral particles. To overcome these limitations, we
have generated codon-optimized vpu and vif genes that bear
no significant nucleotide sequence homology with their
natural counterparts. We show that the proteins produced
by these synthetic genes are highly expressed in autonomous
expression systems and fully functional. We further demon-
strate that the inefficient expression of Vpu and Vif proteins
from their native mRNA is mainly due to RNA instability
caused by poor cytoplasmic export in the absence of the Rev
protein. Nuclear run-on experiments further demonstrate for
the first time that codon optimization does not alter the
initiation or elongation of mRNA. In fact, the mRNA export
inhibition observed for native vpu and vif sequences is
relieved by codon optimization by allowing the synthetic
RNA messages to use a CRM1-independent nuclear export
pathway. These data not only provide valuable information
regarding the mechanism of codon optimization but also
provide the first example of codon optimization of HIV-1
accessory proteins for which no INS or ARE have been do-
cumented. Finally, this study provides two novel vectors for
the autonomous expression of the viral Vpu and Vif proteins.Results
Codon optimization enhances the levels of Vpu and Vif
proteins
To determine the effect of codon optimization on protein
synthesis, we examined the rate of synthesis as well as the
steady-state levels of the synthetic genes under the transcrip-
tional control of the CMV IE promoter. For that purpose, the
vpu and vif genes and their optimized vphu and hvif counter-
parts were cloned in the pcDNA3.1 vector. Reference vectors
for Vpu expression included the full-length HIV-1 molecular
clone pNL4-3 as well as a pNL4-3 derivative, pNL-A1,
lacking the gag and pol genes (Strebel et al., 1988). Vpu-
defective variants of pNL4-3 and pNL-A1 (pNL4-3/Udel
and pNL-A1/Udel, respectively) were included as negative
controls. The vectors were transfected into HeLa cells and
analyzed by Western blotting with a Vpu-specific polyclonal
antibody. As shown in Fig. 1A, the pcDNA-Vphu vector,
bearing the codon-optimized vpu ORF expressed Vpu at
levels comparable to that observed for wild-type Vpu in its
natural context (pNL4-3 and pNL-A1). No Vpu expression
was detectable from the pcDNA-Vpu construct bearing the
wild-type vpu ORF in the same vector context as pcDNA-
Fig. 1. Effect of codon optimization on Vpu and Vif expression. (A)
Steady-state Vpu expression levels. HeLa cells were transfected with 4 Ag
of pNL4-3, pNL4-3/Udel, pNL-A1, or pNL-A1/Udel, and 1.33 Ag of
pcDNA-Vpu, or pcDNA-Vphu. Cell lysates were analyzed 24 h
posttransfection by Western blotting using a rabbit anti-Vpu antiserum
(U2-3). The blots were also probed with an anti-a-tubulin antibody as a
loading control. (B) Rate of translation of Vpu. HeLa cells transfected as
above were labeled with 200 ACi of Trans-35S-methionine for 1 h at 37jC.
Cell lysates were immunoprecipitated with the U2-3 Vpu antibody,
separated on 12.5% SDS-polyacrylamide gels, and the bands visualized
by fluorography. (C) Steady-state Vif expression levels. HeLa cells were
transfected with 4 Ag pNL4-3, pNL4-3/Vif(), pNLA-1, and pNLA-1/
DVif, or 2 Ag of pcDNA-Vif and pcDNA-HVif. Cell lysates were analyzed
24 h posttransfection by Western blot with 1:10,000 dilution of rabbit anti-
Vif polyclonal serum.
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gene relieved an expression block that prevented Vpu from
being expressed in the absence of Rev.
We next examined whether this higher steady-state level
of Vpu was due to enhanced protein synthesis or improved
stability of the optimized protein. To this end, transfected
HeLa cells were metabolically labeled with [35S]-methionine
for 1 h and subjected to anti-Vpu immunoprecipitation. As
shown in Fig. 1B, the results of the metabolic labeling are
remarkably similar to that of the Western blot experiment
presented in Fig. 1A. These data strongly suggest that the
codon optimization affected the rate of synthesis but not the
stability of the synthetic species. Similar experiments were
performed for the vif gene (Fig. 1C). Partial optimization of
vif led to a significant enhancement of protein synthesis from
the CMV promoter (pcDNA-HVif), as compared to the wild-type gene in the same promoter context (pcDNA-Vif). Levels
of Vif protein expression from the pcDNA-HVif construct
were similar to that observed in the native context of the full-
length pNL4-3 (Fig. 1C).
The codon-optimized Vpu and Vif products are biologically
active
We next examined whether the codon-optimized Vpu and
Vif proteins were biologically active when expressed auton-
omously from the CMV promoter-driven pcDNAvector. The
ability of the Vphu protein to enhance viral particle release
was first examined in HeLa cells cotransfected with the Vpu-
defective pNL4-3/Udel construct and increasing amounts of
pcDNA-Vphu. Reverse transcriptase activity measured in
the culture supernatants 24 h postinfection showed that wild-
type NL4-3 expressing Vpu released close to 4-fold more
viral particles than the NL4-3/Udel (Fig. 2A). The addition
of increasing amounts of the non-optimized pcDNA-Vpu
construct had little effect on the efficiency of viral particle
release (Fig. 2A, pNL4-3/Udel + pcDNA-Vpu). In contrast,
as little as 0.3 Ag of co-transfected pcDNA-Vphu enhanced
NL4-3/Udel particle release to the levels observed with wild-
type NL4-3 expressing authentic Vpu in its native context
(Fig. 2A, pNL4-3/Udel + pcDNA-Vphu). The dosage of the
pcDNA-Vphu construct showed that maximum effect was
observed with 0.3–0.6 Ag of transfected plasmid. At the
higher concentration of 1.2 Ag, Vphu was reproducibly
observed to be less effective [Fig. 2A, pNL4-3/Udel +
pcDNA-Vphu (1.2 Ag)]. Because Vpu can induce apoptosis
of cells (Akari et al., 2001; Bour et al., 2001), the low particle
release efficiency observed in the presence of 1.2 Ag of
pcDNA-Vphu is likely due to cytotoxic effects generated by
the high levels of Vpu (Fig. 2B).
To confirm that the increase in cell-free reverse transcrip-
tase activity observed in Fig. 2A was indeed due to the
positive effect of Vphu on particle release, pulse-chase
experiments were performed. HeLa cells were transfected
with the wild-type HIV-1 molecular clone NL4-3 or its Vpu-
defective counterpart NL4-3/Udel in the presence of either
pcDNA-Vpu or pcDNA-Vphu. Cells were pulse-labeled for
30 min with [35S]-methionine and chased for 4 h. At each
time point indicated in Fig. 2C, samples of the cell and
supernatant fractions were collected, lysed, and subjected to
immunoprecipitation with HIV-positive human sera. The
immunoprecipitates were separated on SDS-PAGE and vi-
sualized by fluorography (Fig. 2C). As shown in panel 1,
progeny virus production, as evidenced by the pelletable p24
secreted in the VIRUS fraction, is enhanced by the presence
of Vpu in NL4-3, as compared to the Vpu-defective NL4-3/
Udel. When pcDNA-Vpu was provided in trans to pNL4-3/
Udel, no significant enhancement of particle release was
observed (Fig. 2C, pNL4-3/Udel + Vpu). In contrast,
cotransfection of pcDNA-Vphu led to a significant increase
in particle release, concomitant with the detection of Vphu
protein in the cell fraction (Fig. 2C, pNL4-3/Udel + Vphu).
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the particle release efficiency was calculated as the ratio
between Gag proteins in the VIRUS fraction and the total
Gag proteins in the CELL + VIRUS fractions. When plotted
as a function of chase time, the particle release ratio of pNL4-
3/Udel showed a 6-fold increase in the presence of pcDNA-
Vphu, versus a modest 2-fold increase in the presence of
pcDNA-Vpu (Fig. 2D). The latter phenomenon was at least
in part due to the known enhancing effect of Tat on
transcriptional activity of the CMV promoter leading to
low levels of Vpu expression from the pcDNA-Vpu plasmid
(Kim and Risser, 1993). We and others have previously
reported that Vpu has the ability to enhance particle release
of diverse retroviruses, including HIV-2 (Bour and Strebel,
1996; Gottlinger et al., 1993; Ritter et al., 1996). As
expected, pulse-chase experiments performed with HIV-2
molecular clones showed a close to 8-fold particle release
enhancement in the presence of pcDNA-Vphu but not of
pcDNAVpu (data not shown). Taken together, the HIV-1 and
HIV-2 particle release data indicate that codon-optimized
vpu gene expressed under the transcriptional control of theFig. 2. Effect of Vphu on HIV-1 particle release. (A) HeLa cells were transfected w
and pNL4-3/Udel) or the indicated amounts of pcDNA-Vpu (pNL4-3/Udel + Vpu
performed on 10 Al of culture medium. (B) Five micrograms of cells lysates fr
nitrocellulose membranes, and probed in Western blot with polyclonal antibodies a
200 ACi of Trans-35S-methionine for 30 min, and chased for a total of 4 h. At each
immunoprecipitated with HIV-positive human serum (TP), separated on 12.5% pol
Env and major Gag products are indicated on the left. (D) Particle release efficien
total Gag proteins in the CELL and VIRUS fractions and plotted as a function oCMV promoter behaves similarly to its wild-type counter-
part in the context of the full-length HIV-1 genome. The
engineered vpu gene therefore represents a functional homo-
logue to the native vpu gene without a requirement for
coexpression of the viral Tat and Rev proteins.
We next examined whether the partially optimized vif
gene was biologically functional. The Vif protein functions
in the virus producer cell and its presence is essential for
viral infectivity. Virus produced in restrictive cell types
such as H9 cells requires the presence of a functional Vif
protein for the production of infectious progeny. The
biological functionality of the codon-optimized HVif was
tested by transfecting the restrictive H9 cells with plasmids
encoding either the full-length NL4-3 or its Vif-defective
counterpart (pNL4-3/Dvif). All molecular clones employed
in this experiment were defective for env (NL4-3K1 var-
iants) and pseudotyped with the vesicular stomatitis virus
glycoprotein G (VSV-G) for subsequent infection of MAGI
cells. Plasmids encoding either the wild-type or codon-
optimized Vif were provided in trans. Transfected H9 cells
were lysed 24 h posttransfection and Vif expression wasith 3 Ag of pNL4-3 or pNL4-3/Udel and either 1.2 Ag of pcDNA3.1 (pNL4-3
) or pcDNA-Vphu (pNL4-3/Udel + Vphu). Reverse transcriptase assay was
om transfection in A was separated on 12.5% SDS-PAGE, transferred to
gainst Vpu or tubulin. (C) HeLa cells were transfected as in A, labeled with
indicated time point, cells and virus were lysed in 1% NP-40 lysis buffer and
yacrylamide-SDS gels, and visualized by fluorography. The positions of the
cy was calculated as the ratio of Gag proteins in the VIRUS fraction versus
f chase time.
Fig. 2 (continued).
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major p55, p41, and p24 Gag products were detected in
similar quantities for all samples. Vif expression was
efficient in the case of the NL4-3K1 molecular clone
(Fig. 3A, lane 1) but absent for the NL4-3/Dvif variant,
even in the presence of the non-optimized pcDNA-Vif
construct (Fig. 3A, lanes 2 and 3). When provided in trans,
the pcDNA-HVif plasmid encoding codon-optimized vif
produced detectable levels of Vif, albeit at lower levels
than the wild-type virus (Fig. 3A, lane 4). Progeny virus
collected 24 h posttransfection was quantified and viral
infectivity was assessed by MAGI assay. As shown in Fig.
3B, the absence of Vif in NL4-3K1/Dvif led to a 77%
reduction in infectivity. Providing Vif in trans expressed
from the pcDNA-Vif plasmid had no significant effect on
the infectivity of the NL4-3/DVif-produced virus (Fig. 3B,
lane 3). In contrast, the presence of pcDNA-HVif restoredviral infectivity to over 80% of the level observed for wild-
type virus (Fig. 3B, lane 4). The pcDNA-HVif-optimized
construct therefore demonstrated viral infectivity enhancing
effects at levels close to the wild-type virus.
Effect of optimization on transcription
Codon optimization of the vpu and vif ORFs led to a
remarkable enhancement in the rate of synthesis of the
respective proteins. However, it remains unclear whether
this was due to enhanced translation of the synthetic mRNA
or higher steady-state levels of the mRNA itself. While the
term codon optimization suggests a main effect on transla-
tion (Haas et al., 1996), it has been suggested that codon
optimization could also lead to higher levels of cytoplasmic
mRNA (Kotsopoulou et al., 2000). To address the mecha-
nism by which codon optimization of vpu and vif enhanced
Fig. 3. Biological activity of pcDNA-HVif. (A) Pseudotyped viruses were obtained by transfecting 4  106 H9 cells with (lane 1) pNL43-K1, pCMV-G, and
pcDNA; (lane 2) pNL43-K1/Dvif, pCMV-G, and pcDNA; (lane 3) pNL43-K1/Dvif, pCMV-G, and pcDNA-vif; (lane 4) pNL43-K1/Dvif, pCMV-G, and
pcDNA-HVif (5 mg each, 15 mg in total) by electroporation. Transfected H9 cells were lysed 24 h posttransfection, separated on a 12.5% polyacrylamide-SDS
gel, probed with anti-Vif antibody and anti-p24Gag, and visualized by ECL chemiluminescence. The position of the p55, p41, and p24 major Gag products as
well as Vif are indicated on the left. (B) Twenty-four hours posttransfection, culture supernatants were harvested, filtered, and quantified by p24 ELISA. Viral
infectivity was determined by MAGI assay. Averages of three independent experiments are shown.
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of the respective mRNA. HeLa cells were transfected with
plasmids encoding either the native (pcDNA-Vpu) or opti-
mized (pcDNA-Vphu) vpu gene. Total and cytoplasmic
RNA was extracted, separated by gel electrophoresis and
probed in Northern blotting with a 212-nt probe mapping to
the 5V UTR (Fig. 4A). As expected, no vpu-specific bandwas detected in the pcDNA 3.1() empty vector control.
Interestingly, little or no vpu-specific RNA was detected
from cells transfected with pcDNA-Vpu, suggesting that the
lack of protein expression from this vector is mainly due to
its inability to accumulate vpu-specific mRNA in the nucle-
us or cytoplasm. In marked contrast, RNA produced by the
codon-optimized pcDNA-Vphu was abundant both in the
Fig. 4. Effect of codon optimization on RNA steady-state levels. (A) Vpu and Vphu RNA levels. HeLa cells were transfected with 2 Ag pcDNA3.1, pcDNA-
Vpu, or pcDNA-Vphu. Five micrograms of total and cytoplasmic RNA isolated 24 h posttransfection was separated on a 1% denaturing agarose gel and
transferred onto nitrocellulose membrane. A 212-bp biotinylated DNA probe containing sequences complementary to the 5V UTR of Vpu and Vphu was
hybridized to the RNA at 42jC overnight and detected by chemiluminescence. (B) Comparison of total versus cytoplasmic Vif/HVif RNA levels. HeLa cells
were transfected with 2 Ag pcDNA3.1, pcDNA-Vif, or pcDNA-HVif. Five micrograms of total and cytoplasmic RNA isolated 24 h posttransfection was
separated on a 1% denaturing agarose gel and transferred onto nitrocellulose membrane. A 60-bp biotinylated DNA probe containing sequences
complementary to the 5V UTR of Vif and HVif was hybridized to the RNA at 37jC overnight and detected by chemiluminescence.
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performed for the optimized vif gene (Fig. 4B). In the case
of vif, low RNA expression could be detected from the non-
optimized pcDNA-Vif construct. However, as was the case
for vpu, a significant enhancement of both total and cyto-
plasmic RNA levels was observed following codon optimi-
zation (Fig. 4B, pcDNA-HVif). These data strongly suggest
that the main effect of codon optimization of both the vpu
and vif genes is at the RNA level whereby higher cytoplas-
mic mRNA steady-state levels could account for most of the
observed increase in protein levels.
To rule out the possibility that the lack of RNA expres-
sion from the non-optimized species was due to low
transfection efficiency or instability of the plasmid DNA,
Southern blots were performed with low molecular weight
DNA from cells transfected with both the authentic and
codon-optimized Vpu-expressing constructs. No difference
was observed in the nuclear accumulation of the pcDNA-
Vpu and pcDNA-Vphu plasmids, indicating that both con-structs were properly transfected and had similar stability in
cells (data not shown).
Effect of codon optimization on transcriptional initiation
and elongation
To better define the mechanism by which codon optimi-
zation enhances the steady-state levels of vpu mRNA, we
performed nuclear run-on (NRO) experiments to assess the
rate of initiation and elongation of the vpu message. To
provide a global view of the transcriptional process, mul-
tiple DNA probes were used that spanned the entire vpu
RNA. As shown in Fig. 5A, three separate probes were
designed for the vpu and vphu messages. The 5V UTR probe
spans the transcriptional initiation site and provides a
measure of the early transcription events. The 5V and 3V
coding probes allowed us to monitor the elongation effi-
ciency of the transcribed RNA and assess whether prema-
ture termination was occurring. A probe mapping to the
Fig. 5. Transcriptional rate of wild-type and codon-optimized vpu genes. (A) Schematic representation of the three cDNA probes used to detect the vpu and
vphu mRNAs. (B) 293T cells were transfected with 2 Ag of pcDNA-Vpu and pcDNA-Vphu and 24 h later nuclei were isolated and used in nuclear run-on
assays. Nuclei were 32P-labeled in vitro and hybridized to nylon membranes blotted with cDNA fragments diagramed in A. cDNA from an unrelated cellular
gene (caveolin-1) was used as a control for specificity, and a probe for the neomycin resistance gene was used for transfection and loading controls.
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pcDNA-Vpu and pcDNA-Vphu constructs served as an
internal control for transfection efficiency. Cells were trans-
fected with pcDNA-Vpu or pcDNAVphu, nuclei were
isolated, and NROs were performed as described in Materi-
als and methods. Nylon membranes were blotted with the
various probes described in Fig. 5A and hybridized with
100,000 cpm of radiolabeled RNA from the NRO reactions.
An unrelated cellular gene cDNA (caveolin-1) was used as
a control for specificity and a probe for the neo gene was
used for transfection and loading controls. As shown in Fig.
5B, RNA encoding the non-optimized Vpu was readily
detectable, in contrast to the situation observed with steady-
state Northern blots (see Fig. 4). In addition, all the
intermediates of the full-length vpu mRNA, from the 5Vto
the 3V UTRs, were detected, indicating proper initiation and
elongation of the non-optimized message (Fig. 5B, Vpu).
Similar results were obtained when a probe spanning the
complete coding region for these genes were used (data not
shown). Results of the NRO also indicated that codon
optimization of the vpu ORF did not lead to a detectable
improvement in the rate of initiation or elongation of the
vphu message (Fig. 5B, Vphu). The variations in relative
intensity between probes for the same gene product are
likely due to differences in affinity between the probes rather
than a direct measure of the abundance of the different
species of RNA. Taken together, these data show that the
higher steady-state levels of vphu RNA observed after codonoptimization are not due to enhanced transcriptional initia-
tion or elongation.
Codon optimization increases the nuclear stability of the
Vpu mRNA
Results from the NRO experiments showed that neither
the initiation nor the elongation of the vpu RNA were
affected by codon optimization. Therefore, our inability to
detect steady-state levels of vpu RNA is likely due to nuclear
or translation-coupled degradation of the mRNA. To differ-
entiate between these two possibilities, we performed North-
ern blot analysis of the vpu and vphu RNA in cellular RNA
fractions using a full-length probe spanning the entire
transcribed RNA to detect degradation products. In the case
of vphu, a discrete band corresponding to the full-length
mRNA was detected in both the nuclear (Fig. 6, Vphu, N)
and cytoplasmic fractions (Fig. 6, Vphu, C). In addition, a
large proportion of the vphu RNA was isolated from the
cytoplasmic fraction, indicating efficient nuclear export. In
sharp contrast, no discrete band corresponding to full-length
vpu RNA was detected in the nuclear or cytoplasmic frac-
tions (Fig. 6, Vpu). Instead, a smear corresponding to
products in various stages of degradation was detected in
the nuclear fraction (Fig. 6, Vpu, N). Moreover, the smear
was absent in the cytoplasmic fraction, indicating that the
bulk of the degradation occurred in the nucleus and that no
full-length or partial vpu RNAwas exported to the cytoplasm
Fig. 6. Subcellular distribution of steady-state levels of vpu and vphu
mRNA. 293T cells were transfected with 2 Ag of pcDNA-Vpu and pcDNA-
Vphu and 24 h later total RNA was extracted from nuclear (N) and
cytoplasmic (C) fractions or unfractionated cells (T) and analyzed by
Northern blotting with 32P-labeled Vpu and Vphu cDNA probes. RNA
from mock-transfected cells (M) and h-actin were used as a control for
specificity and loading, respectively.
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account for the signal detected in the NRO experiments of
pcDNA-vpu transfected cells. Also, longer forms of vphu
mRNA and a small amount of vpu mRNA were detected in
the cytoplasmic fractions. These products could represent
read-through of the poly A signal in pcDNA3. Taken
together, these data allow us to conclude that non-optimized
vpu fails to express Vpu protein in the absence of RevFig. 7. Effect of LMB treatment on Vpu synthesis. HeLa cells were transfected w
divided into three equal aliquots and incubated with 0, 10, or 25 nM LMB for 2 h
presence or absence of LMB. Cell lysates were immunoprecipitated with antibodie
fluorography. Bands were quantified and plotted as the ratio of LMB-treated versbecause of a lack of cytoplasmic export as well as nuclear
degradation of its mRNA. Codon optimization relieves this
block by stabilizing the RNA in the nucleus and allowing its
efficient export to the cytoplasm.
The codon-optimized vphu message uses a
CRM1-independent nuclear export pathway
One possible explanation for the nuclear instability of the
non-optimized vpu mRNA is that the RNA is not efficiently
exported from the nucleus where its prolonged presence
leads to enhanced degradation. The ability of the codon-
optimized vpu message to utilize a different nuclear export
pathway would explain the results presented in Fig. 6 and
provide a mechanistic explanation for the drastic effect of
codon optimization on Vpu expression. It has been reported
that Rev-dependent HIV-1 mRNAs such as the gag mRNA
use the CRM1 Ran-GTP nuclear export pathway and that
inhibiting CRM1 function with the drug leptomycin B
(LMB) has a pronounced negative effect on the nuclear
export of Rev-dependent HIV RNA (Graf et al., 2000; Wolff
et al., 1997). We therefore examined the effect of LMB
treatment on the rate of Vpu synthesis. Vpu was expressed
from its native ORF in a Rev-dependent context from the
pNL-A1 construct. The pNL-A1 plasmid also expresses the
env gene, providing an internal control for another Rev-
dependent message. Vphu was expressed from pcDNA-
Vphu in the absence of Rev. Twenty-four hours posttrans-
fection, cells were divided into three identical aliquots and
pretreated with 0, 10, or 25 nM LMB at 37jC for 2 h. Cellsith 9 Ag pNL-A1 (Env and Vpu) or 3 Ag pcDNA-Vphu (Vphu). Cells were
at 37jC. Cells were labeled with [35S]-methionine for 1.5 h at 37jC in the
s against Vpu, Env, or tubulin, separated by SDS-PAGE, and visualized by
us untreated control.
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methionine in the presence or absence of the indicated
amounts of LMB. Cell lysates were immunoprecipitated
with antibodies to Vpu, Env, or tubulin, separated by SDS-
PAGE, and visualized by fluorography (not shown). Bands
were quantified with a Bio-Image analyzer and plotted as
shown in Fig. 7. As expected, LMB treatment had a
significant negative effect on the synthesis of the Rev-
dependent Env protein, leading to a 50% reduction in Env
protein synthesis during the 90-min labeling (Fig. 7, Env). A
similar decrease was observed for Vpu when produced in the
context of the pNL-A1 plasmid bearing the native vpu ORF
(Fig. 7, Vpu). In contrast, LMB had little effect on the
synthesis of Vpu when expressed from the codon-optimized
pcDNA-Vphu plasmid, even at the highest LMB concentra-
tion used (Fig. 7, Vphu). As an internal control, we also
examined the synthesis of the cellular tubulin gene both in
cells transfected with either pNL-A1 or pcDNA-Vphu. As
shown in Fig. 7, tubulin synthesis was unaffected by the
presence of LMB, further demonstrating that the effect of the
drug was specific for CRM1-dependent RNAs and not the
result of general toxicity (Fig. 7, Tubulin). These data
indicate that codon optimization of the vpu gene led to an
increase in RNA stability and accelerated nuclear export by
allowing the vphu mRNA to utilize a CRM1-independent
nuclear export pathway.Discussion
This work presents the first example of codon optimiza-
tion of small HIV-1 accessory genes. We demonstrated that
partial or complete codon optimization of the vpu and vif
ORFs led to a dramatic enhancement of protein synthesis in
the absence of the viral regulatory proteins Tat and Rev and
that this was attributable to higher levels of translatable
mRNA in the cytoplasm. In the case of the native vpu gene,
we further demonstrated that the lack of protein synthesis
was due to nuclear retention and degradation of its mRNA.
In contrast, the mRNA produced by the codon-optimized
gene was stable and efficiently exported to the cytoplasm.
One important question that remains to be addressed is
whether the native vpu message is intrinsically unstable
due to the presence of destabilizing sequences or whether
degradation is a consequence of the prolonged presence of
the RNA in the nucleus. Our experiment using the CRM1
blocker LMB favors the latter hypothesis. Indeed, we
showed that, in contrast to the native message, the codon-
optimized vpu RNA was insensitive to LMB, suggesting a
mechanism by which codon optimization relieved a nuclear
export block. However, it is also possible that destabilizing
sequences were still present in the codon-optimized message
but that access to a new nuclear export pathway allowed the
RNA to exit the nucleus before a functional degradation
complex could be formed. Our codon-optimized constructs
should provide ideal tools to study these questions in moredetails and gain new insight into the mechanisms of Rev-
regulated nuclear export and RNA stability. Indeed, the small
size of the vpu ORF will make it easier than in the case of
gag, pol, or env to map RNA sequences involved in nuclear
retention and/or RNA degradation.
Among the factors that contribute to RNA instability, a
strong emphasis has been placed on the overall AU content
of the message and the presence of discrete destabilizing
sequences such as AREs (Hollams et al., 2002). AREs vary
in size and sequence but often contain AUUUA repeats in or
near AU-rich sequences. ARE sequences provide binding
sites for a variety of RNA binding proteins that can affect all
stages of the RNA life cycle, from transcription to nuclear
export to degradation (Hollams et al., 2002). In the case of
the HIV-1 gag message, a number of factors have been
implicated in the poor expression of Gag proteins in the
absence of Rev and to account for the enhanced expression
following codon optimization. Most prominent among those
are the inactivation of discrete INS or the decrease in the
overall AU content across the length of the coding sequence
(Graf et al., 2000; zur Megede et al., 2000). Yet, it is unlikely
that these factors explain our results with vpu mRNA
because no INS motifs have been defined in vpu and no
ARE sequences conforming to the AUUUA consensus exist
in vpu. However, the strategy employed here for the codon
optimization of vpu resulted in a significant decrease in the
AU content of the vpu ORF; from 63% for the wild type to
42% for the synthetic vphu. Interestingly, a CD4-Vpu
chimera, CD4U, which we previously found to express
Vpu in a Rev-independent manner when fused to the CD4
ectodomain (Bour et al., 2001), had an AU content of 49%.
These data suggest that it may be the overall AU content of
an mRNA rather than the presence of defined destabilizing
sequence elements in the vpu ORF such as ARE that can
confer instability to otherwise stable messages. These results
further suggest that a threshold of AU content might be key
to the ability of a given RNA to avoid nuclear degradation.
Alternatively, it is possible that sequences near the 5V end of a
message are the main determinants of RNA stability and that
introducing stabilizing CD4 sequences at the 5V of the vpu
coding sequence was sufficient to abrogate the negative
influence of the vpu ORF on RNA stability. While this
may be in contrast with the finding that most ARE sequences
are located in the 3V UTR of unstable mRNAs, there is
experimental evidence that optimization of the first few
codons on the 5V end of poorly expressed genes contributes
the most to the increased protein expression (Humphreys et
al., 2000; Kim et al., 1997; Vervoort et al., 2000). The
importance of 5V sequences on RNA stability is further
illustrated by our finding that partially optimizing the 5V
end of the vif gene was sufficient to stabilize its mRNA and
enhance protein production.
Codon-optimized gag–pol genes have been used for the
construction of lentiviral vectors that can transduce a variety
of cell types. In addition to enhanced expression, the
optimized synthetic genes offer a higher level of safety from
K.-L. Nguyen et al. / Virology 319 (2004) 163–175 173homologous recombination because they lack the 5V UTR
common to all natural HIV messages and bear minimal
sequence homology with the coding region of wild-type
genes (Wagner et al., 2000). To minimize the chances of
recombination, most recombinant vectors using codon-opti-
mized gag or env lack accessory genes. While often dis-
pensable for viral propagation in vitro, accessory genes such
as vpu and vif provide important functions during the viral
life cycle. The Vpu protein has the ability to enhance the rate
of viral particle production while Vif enhances the infectivity
of progeny virus produced in restricted cell types. It would
therefore be beneficial to include such accessory factors in
the design of recombinant therapeutic lentiviruses (Kobinger
et al., 1997; Srinivasakumar and Schuening, 1999). The
codon-optimized vpu and vif genes described in this study
therefore have the potential to improve the yield and versa-
tility of current retroviral vectors when these are produced
from cells that are not permissive for these genes. In
addition, the ability to express the vpu gene autonomously
will allow better fine-tuning of the expression levels, there-
fore avoiding the toxicity associated with high levels of Vpu
expression (Akari et al., 2001; Bour et al., 2001).Materials and methods
Cell culture and transfection
HeLa and 293T cells were maintained in Dulbecco’s
modified Eagle’s medium containing 10% (v/v) fetal bovine
serum (FBS) and supplemented with L-glutamine and anti-
biotics (penicillin–streptomycin). For transfections, cells
were grown to near confluence in 25-cm2 flasks. Trans-
fections in HeLa cells were performed with TransIT-LT1
(Panvera), according to the manufacturer’s instructions.
Transfections in 293T cells were performed by the calcium
phosphate co-precipitation method, as described previously
(Llano et al., 2002). For preparation of pseudotyped virus,
H9 cells were transfected by electroporation using a Gene
Pulser II (Bio-Rad) with 5 Ag each of pNL43-K1 or pNL43-
K1Dvif, pNL-A1 or pNL-A1Dvif and pCMV-VSVG. The
culture supernatants were harvested 24 h after transfection,
filtered through 0.45 Am filters, and concentrated by ul-
tracentrifugation through 20% sucrose for 1 h at 25,000 rpm
using an SW41 rotor (Beckman). The infectivity of the
pseudotyped viruses obtained was measured by MAGI assay
as previously described (Kimpton and Emerman, 1992).
Plasmids
pNLA-1 is a derivative of pNL4-3 (Adachi et al., 1986),
lacking the gag and pol genes but expressing all other viral
genes. The pNLA-1/U-del construct is derived from pNLA-1
(Strebel et al., 1987), and carries a deletion that inactivates
the vpu gene (Bour et al., 1996; Klimkait et al., 1990).
pcDNA-Vpu contains the full-length native vpu gene frompNL4-3 cloned into the EcoRI and KpnI restriction sites of
pcDNA 3.1() (Invitrogen). pcDNA-Vphu is derived from
pcDNA-Vpu and expresses Vpu from the codon-optimized
vpu sequence (Vphu) cloned into the MscI–Acc65I restric-
tion sites. The Vphu gene was constructed by asymmetric
PCR using a series of three overlapping oligonucleotide
fragments 137, 124, and 106 nt in length, respectively. The
Vpu initiation codon was optimized according to the Kozak
context rules (Kozak, 1987). To this effect, the C at position
+4 was changed to a G, which further required changing the
nucleotides at +5 and +6, resulting in a glutamine to valine
change at amino acid position 2. Second, a GCCGCC
sequence was introduced immediately upstream of the
ATG initiation codon. In addition, each vpu codon was
modified to conform with the reported codon usage of highly
expressed human genes (Kotsopoulou et al., 2000). Two
valine codons at positions 6 and 13 were not fully optimized
to avoid creating additional MscI sites that would have
interfered with subsequent cloning. In these cases, the
GTC codon for valine was used instead of the more common
GTG codon. The internal env initiation codon was inacti-
vated by substituting a C for a T at position 211. Lastly, two
unique restriction sites were introduced, neither of which
changed the Vpu amino acid sequence: an AgeI at position
165 and an AfeI site at position 229. This codon optimization
procedure led to a significant decrease in the AU content of
the vpu ORF; from 63% for the wild type to 42% for the
synthetic vphu. However, the difference was less pronounced
over the entire length of the Vpu-encoding mRNA (54% for
the wild type versus 44% for the vphu mRNA). pcDNA-Vif
was generated by cloning the wild-type Vif gene from pNL4-
3 into pcDNA3.1() using the EcoRI–BamHI restriction
sites. pcDNAHVif is the optimized Vif clone containing the
partially codon-optimized Vif gene cloned into pcDNA-Vif
using the EcoRI–PflMI restriction sites. The HVif gene was
constructed by asymmetric PCR as described above for
Vphu. The N-terminal 84 of the 191 codons of the vif gene
were optimized. A unique AgeI restriction site at position
8 was created in the synthetic gene, preventing the arginine at
position 4 from being fully optimized. pROD1014 is a
chimeric virus containing the env gene from the HIV-2
ROD14 isolate in the context of the ROD10 HIV-2 full-
length molecular clone (Bour et al., 1999). Construct
pROD1014RK/TA is a double Env mutant of pROD1014
containing an arginine to lysine substitution at position 422
and a threonine to alanine substitution at position 528 (Bour
et al., 2003).
Reverse-transcriptase assays
Virus-containing culture supernatants were collected
from transfected HeLa cells 24 h posttransfection and
cellular debris removed by centrifugation (16,000  g, 1
min). Reverse-transcriptase assays were performed on 10
Al of virus supernatant as described previously (Willey et
al., 1988).
rology 319 (2004) 163–175Pulse-chase experiments and immunoprecipitations
For pulse-chase experiments, transfected HeLa cells were
collected 24 h posttransfection, labeled with Trans-35S-
methionine (2 ACi/Al) and subjected to Chase and immuno-
precipitation as previously described (Bour et al., 2003).
Western blotting
Cell lysates were prepared from transfected HeLa cells 24
h posttransfection with 1% NP-40 lysis buffer. Five to 10 Ag
of total proteins was separated on polyacrylamide-SDS gels.
Proteins were transferred onto nitrocellulose membranes
using an electroblotter (Genomic Solutions) and probed
sequentially with either 1:2000 dilution of rabbit anti-Vpu
(U2-3) or 1:10,000 dilution of rabbit anti-Vif and 1:4000
dilution of horseradish peroxidase (HRP)-labeled anti-rabbit
IgG. For loading controls, the blots were probed sequentially
with 1:2000 dilution of mouse anti-a-tubulin and 1:4000 di-
lution of HRP-labeled anti-mouse IgG. Proteins were visu-
alized using the ECLWestern blotting reagent (Amersham).
Isolation of nuclear and cytoplasmic fractions
Nuclear and cytoplasmic fractions were isolated accord-
ing to the method of Greenberg and Ziff (1984), with minor
modifications. Briefly, 293T cells grown in six-well plates
were harvested in lysis buffer containing 0.25% NP-40 and
incubated in ice for 15 min. Nuclear and cytoplasmic
fractions were separated by spinning at 500  g for 5
min. Nuclei were washed once in NP-40 lysis buffer and
purity was evaluated by optical microscopy. Usually, greater
than 95% purity was obtained. Cytoplasmic fractions were
further clarified by spinning at 1200  g for 10 min.
Northern blotting
RNA from nuclear and cytoplasmic fractions and from
unfractionated cells were isolated with Trizol (Invitrogen)
and treated with 1 unit of RQ1 RNAse-free DNAse (Prom-
ega) per microgram of RNA. RNAs (5 Ag each) were
separated in 1.2% agarose–formaldehyde gels and trans-
ferred to nylon membranes. Prehybridization (2 h) and
hybridization (overnight) were done at 42jC in ULTRAhyb
buffer (Ambion). Probes (32P-labeled Vpu or Vphu cDNA
fragments, or 32P-labeled h-actin antisense oligonucleotide)
were used at 106 cpm/ml of hybridization buffer. Mem-
branes were washed at room temperature 3 times for 5 min
in 2 SSC/0.5% SDS and 2 times for 15 min at 60jC (Vpu
or Vphu probes) or 50jC (h-actin) in 0.1 SSC/0.5% SDS.
Nuclear run-on
293T cells were transfected with 2 Ag of pcDNA-Vphu or
pcDNAVpu. Twenty-four hours after transfection, nuclei
were isolated as described above and used in nuclear run-
K.-L. Nguyen et al. / Vi174on assays. Freshly isolated nuclei corresponding to 3  106
transfected 293T cells were used per nuclear run-on reaction
(Madisen et al., 1998). Unincorporated 32P-UTP was re-
moved using NucAway spin columns (Ambion) and radio-
labeled RNAwas measured in a TopCount NXT Microplate
Scintillation and Luminescence Counter (Packard). Five
micrograms of cDNA probes was blotted on nylon mem-
branes after alkali denaturation. Membranes were prehybri-
dized for 2 h and hybridized overnight at 65jC with 105
cpm/ml of in vitro transcribed 32P-RNA, washed with 2
SSC and incubated for 30 min in 2 SSC containing 1 Ag/ml
of ribonuclease A at 37jC.
Southern blotting
Low molecular weight DNA was extracted from the
nuclear and cytoplasmic fractions of transfected 293T cells
by Hirt extraction (Hirt, 1967), separated on 0.8% agarose
gels in 1 TAE buffer (1 Ag Hirt DNA/lane), alkali dena-
tured, and transferred to nylon membranes. Membranes were
prehybridized for 3 h at 42jC and then hybridized overnight
in the presence of 50% formamide with 32P-labeled Vpu or
Vphu cDNA fragments (106 cpm/ml).Acknowledgments
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